journal article·2024-10Open access

Sirtuin 5‐Mediated Desuccinylation of ALDH2 Alleviates Mitochondrial Oxidative Stress Following Acetaminophen‐Induced Acute Liver Injury

Qiwen Yu, Jiakai Zhang, Jiye Li, Yaodong Song, Jie Pan, Chaopeng Mei, Mengwei Cui, Qianqian He, Haifeng Wang, Huihui Li, Bo Cheng, Yan Zhang, Wenzhi Guo, Changju Zhu, Sanyang Chen

Advanced Science· Volume 11· Issue 39

Abstract

Abstract Acetaminophen (APAP) overdose is a major cause of drug‐induced liver injury. Sirtuins 5 (SIRT5) has been implicated in the development of various liver diseases. However, its involvement in APAP‐induced acute liver injury (AILI) remains unclear. The present study aimed to explore the role of SIRT5 in AILI. SIRT5 expression is dramatically downregulated by APAP administration in mouse livers and AML12 hepatocytes. SIRT5 deficiency not only exacerbates liver injury and the inflammatory response, but also worsens mitochondrial oxidative stress. Conversely, the opposite pathological and biochemical changes are observed in mice with SIRT5 overexpression. Mechanistically, quantitative succinylome analysis and site mutation experiments revealed that SIRT5 desuccinylated aldehyde dehydrogenase 2 (ALDH2) at lysine 385 and maintained the enzymatic activity of ALDH2, resulting in the suppression of inflammation and mitochondrial oxidative stress. Furthermore, succinylation of ALDH2 at lysine 385 abolished its protective effect against AILI, and the protective effect of SIRT5 against AILI is dependent on the desuccinylation of ALDH2 at K385. Finally, virtual screening of natural compounds revealed that Puerarin promoted SIRT5 desuccinylase activity and further attenuated AILI. Collectively, the present study showed that the SIRT5‐ALDH2 axis plays a critical role in AILI progression and might be a strategy for therapeutic intervention.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Sirtuins and Resveratrol in Medicine · Heme Oxygenase-1 and Carbon Monoxide · Drug-Induced Hepatotoxicity and Protection

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Emergency Medicine The First Affiliated Hospital of Zhengzhou University Zhengzhou Henan 450052 China

Henan Medical Key Laboratory of Emergency and Trauma Research Zhengzhou Henan 450052 China

Henan Emergency and Trauma Medicine Engineering Research Center Zhengzhou Henan 450052 China

Department of Hepatobiliary and Pancreatic Surgery The First Affiliated Hospital of Zhengzhou University Zhengzhou Henan 450052 China

Henan Key Laboratory for Digestive Organ Transplantation The First Affiliated Hospital of Zhengzhou University Zhengzhou Henan 450052 China

Funding

National Natural Science Foundation of China

References (52)

Show source-provided references
1. 10.1248/bpb.b19-0072210.1248/bpb.b19-00722 ↗
2. 10.1016/S0140-6736(19)31894-X10.1016/S0140-6736(19)31894-X ↗
3. 10.1002/ncp.1045910.1002/ncp.10459 ↗
4. 10.1080/15563650.2023.228692210.1080/15563650.2023.2286922 ↗
5. 10.1016/j.phrs.2020.10510210.1016/j.phrs.2020.105102 ↗
6. 10.1073/pnas.81.5.132710.1073/pnas.81.5.1327 ↗
7. 10.3389/fphar.2023.112263210.3389/fphar.2023.1122632 ↗
8. 10.1016/j.redox.2018.04.01910.1016/j.redox.2018.04.019 ↗
9. 10.1016/j.jhep.2004.09.01510.1016/j.jhep.2004.09.015 ↗
10. 10.1177/1535370222114756310.1177/15353702221147563 ↗
11. 10.2174/13816121079103396910.2174/138161210791033969 ↗
12. 10.1007/s11064-019-02780-x10.1007/s11064-019-02780-x ↗
13. 10.1186/s40779-022-00367-210.1186/s40779-022-00367-2 ↗
14. 10.1016/j.gendis.2022.10.02810.1016/j.gendis.2022.10.028 ↗
15. 10.1016/j.biopha.2023.11571310.1016/j.biopha.2023.115713 ↗
16. 10.15252/embr.20174512410.15252/embr.201745124 ↗
17. Hu Y. · Antioxid Redox Sign · 2023
18. 10.1186/s12953-016-0092-y10.1186/s12953-016-0092-y ↗
19. 10.1016/j.tcb.2014.04.00210.1016/j.tcb.2014.04.002 ↗
20. 10.1016/j.tem.2013.12.00110.1016/j.tem.2013.12.001 ↗
21. 10.1080/10409238.2018.145807110.1080/10409238.2018.1458071 ↗
22. 10.1016/j.ejmech.2022.11436310.1016/j.ejmech.2022.114363 ↗
23. 10.1126/science.120786110.1126/science.1207861 ↗
24. 10.1016/j.cmet.2013.11.01310.1016/j.cmet.2013.11.013 ↗
25. 10.1016/j.phymed.2022.15399410.1016/j.phymed.2022.153994 ↗
26. 10.1016/j.yexcr.2022.11331910.1016/j.yexcr.2022.113319 ↗
27. 10.1016/j.redox.2016.10.00110.1016/j.redox.2016.10.001 ↗
28. 10.1124/dmd.123.00127910.1124/dmd.123.001279 ↗
29. 10.1038/s41467-017-01970-x10.1038/s41467-017-01970-x ↗
30. 10.1016/j.phymed.2020.15324110.1016/j.phymed.2020.153241 ↗
31. 10.1016/j.bbadis.2019.05.01210.1016/j.bbadis.2019.05.012 ↗
32. 10.3390/antiox1203062810.3390/antiox12030628 ↗
33. 10.1016/j.jep.2023.11622710.1016/j.jep.2023.116227 ↗
34. 10.3389/fnagi.2021.64672910.3389/fnagi.2021.646729 ↗
35. 10.1016/j.jhep.2023.09.02010.1016/j.jhep.2023.09.020 ↗
36. 10.3390/cancers1407161010.3390/cancers14071610 ↗
37. 10.1042/EBC2018006110.1042/EBC20180061 ↗
38. 10.1038/s41401-021-00841-y10.1038/s41401-021-00841-y ↗
39. 10.1016/j.molcel.2013.06.00110.1016/j.molcel.2013.06.001 ↗
40. 10.1038/nchembio.49510.1038/nchembio.495 ↗
41. 10.1038/s41401-022-00945-z10.1038/s41401-022-00945-z ↗
42. 10.1016/j.yjmcc.2019.11.15910.1016/j.yjmcc.2019.11.159 ↗
43. 10.1152/physrev.00017.201310.1152/physrev.00017.2013 ↗
44. Maeda M. · Lab. Invest. · 1988 · 59 · 75
45. 10.1016/j.redox.2023.10299410.1016/j.redox.2023.102994 ↗
46. 10.1016/j.neuro.2018.06.00510.1016/j.neuro.2018.06.005 ↗
47. 10.1016/j.freeradbiomed.2016.02.00110.1016/j.freeradbiomed.2016.02.001 ↗
48. 10.1016/j.redox.2022.10257710.1016/j.redox.2022.102577 ↗
49. 10.1016/j.jep.2022.11514610.1016/j.jep.2022.115146 ↗
50. 10.1016/j.taap.2020.11498210.1016/j.taap.2020.114982 ↗
51. 10.1080/10715762.2018.145904210.1080/10715762.2018.1459042 ↗
52. 10.1002/fsn3.360910.1002/fsn3.3609 ↗